3D Printing of a Multi-Layered Polypill Containing Six Drugs Using a Novel Stereolithographic Method
Tóm tắt
Three-dimensional printing (3DP) has demonstrated great potential for multi-material fabrication because of its capability for printing bespoke and spatially separated material conformations. Such a concept could revolutionise the pharmaceutical industry, enabling the production of personalised, multi-layered drug products on demand. Here, we developed a novel stereolithographic (SLA) 3D printing method that, for the first time, can be used to fabricate multi-layer constructs (polypills) with variable drug content and/or shape. Using this technique, six drugs, including paracetamol, caffeine, naproxen, chloramphenicol, prednisolone and aspirin, were printed with different geometries and material compositions. Drug distribution was visualised using Raman microscopy, which showed that whilst separate layers were successfully printed, several of the drugs diffused across the layers depending on their amorphous or crystalline phase. The printed constructs demonstrated excellent physical properties and the different material inclusions enabled distinct drug release profiles of the six actives within dissolution tests. For the first time, this paper demonstrates the feasibility of SLA printing as an innovative platform for multi-drug therapy production, facilitating a new era of personalised polypills.
Từ khóa
Tài liệu tham khảo
Fonseca, 2000, Effect of Metformin and Rosiglitazone Combination Therapy in Patients With Type 2 Diabetes Mellitus, JAMA, 283, 1695, 10.1001/jama.283.13.1695
Gradman, 2010, Combination therapy in hypertension, J. Am. Soc. Hypertens., 4, 42, 10.1016/j.jash.2010.02.005
Cruz, 2018, Treatment of Multidrug-resistant Tuberculosis Infection in Children, Pediatr. Infect. Dis. J., 37, 831, 10.1097/INF.0000000000002087
Weverling, 1998, Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy, AIDS, 12, F117, 10.1097/00002030-199811000-00003
Payne, 2011, Polypharmacy: One of the greatest prescribing challenges in general practice, Br. J. Gen. Pract., 61, 83, 10.3399/bjgp11X556146
Bangalore, 2007, Fixed-dose combinations improve medication compliance: A meta-analysis, Am. J. Med., 120, 713, 10.1016/j.amjmed.2006.08.033
Castellano, 2014, A polypill strategy to improve adherence: Results from the FOCUS project, J. Am. Coll. Cardiol., 64, 2071, 10.1016/j.jacc.2014.08.021
Connor, 2004, Do fixed-dose combination pills or unit-of-use packaging improve adherence? A systematic review, Bull. World Health Organ., 82, 935
Yusuf, 2009, Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): A phase II, double-blind, randomised trial, Lancet, 373, 1341, 10.1016/S0140-6736(09)60611-5
Patel, 2010, Preservation of Bioavailability of Ingredients and Lack of Drug-Drug Interactions in a Novel Five-Ingredient Polypill (Polycap™), Am. J. Cardiovasc. Drugs, 10, 95, 10.2165/11532170-000000000-00000
Webster, 2017, Putting polypills into practice: Challenges and lessons learned, Lancet, 389, 1066, 10.1016/S0140-6736(17)30558-5
Alomari, 2018, Printing T3 and T4 oral drug combinations as a novel strategy for hypothyroidism, Int. J. Pharm., 549, 363, 10.1016/j.ijpharm.2018.07.062
Tian, 2018, Oral disintegrating patient-tailored tablets of warfarin sodium produced by 3D printing, Drug Dev. Ind. Pharm., 44, 1918, 10.1080/03639045.2018.1503291
Vuddanda, 2018, Personalisation of warfarin therapy using thermal ink-jet printing, Eur. J. Pharm. Sci., 117, 80, 10.1016/j.ejps.2018.02.002
Goyanes, 2015, Fabrication of controlled-release budesonide tablets via desktop (FDM) 3D printing, Int. J. Pharm., 496, 414, 10.1016/j.ijpharm.2015.10.039
Alomari, 2015, Personalised dosing: Printing a dose of one’s own medicine, Int. J. Pharm., 494, 568, 10.1016/j.ijpharm.2014.12.006
Breitkreutz, 2019, On-demand manufacturing of immediate release levetiracetam tablets using pressure-assisted microsyringe printing, Eur. J. Pharm. Biopharm., 134, 29, 10.1016/j.ejpb.2018.11.008
Basit, A.W., and Gaisford, S. (2018). 3D Printing of Pharmaceuticals, Springer International Publishing.
Awad, A., Fina, F., Trenfield, S.J., Patel, P., Goyanes, A., Gaisford, S., and Basit, A.W. (2019). 3D Printed Pellets (Miniprintlets): A Novel, Multi-Drug, Controlled Release Platform Technology. Pharmaceutics, 11.
Vithani, 2019, A Proof of Concept for 3D Printing of Solid Lipid-Based Formulations of Poorly Water-Soluble Drugs to Control Formulation Dispersion Kinetics, Pharm. Res., 36, 102, 10.1007/s11095-019-2639-y
Vithani, 2018, An Overview of 3D Printing Technologies for Soft Materials and Potential Opportunities for Lipid-based Drug Delivery Systems, Pharm. Res., 36, 4, 10.1007/s11095-018-2531-1
Linares, 2019, Printfills: 3D printed systems combining fused deposition modeling and injection volume filling. Application to colon-specific drug delivery, Eur. J. Pharm. Biopharm., 134, 138, 10.1016/j.ejpb.2018.11.021
Hsiao, W.-K., Lorber, B., Reitsamer, H., and Khinast, J. (2017). 3D printing of oral drugs: A new reality or hype?. Expert Opin. Drug Deliv., 1–4.
Awad, 2018, Reshaping drug development using 3D printing, Drug Discov. Today, 23, 1547, 10.1016/j.drudis.2018.05.025
Fina, 2018, Fabricating 3D printed orally disintegrating printlets using selective laser sintering, Int. J. Pharm., 541, 101, 10.1016/j.ijpharm.2018.02.015
Fina, 2017, Selective laser sintering (SLS) 3D printing of medicines, Int. J. Pharm., 529, 285, 10.1016/j.ijpharm.2017.06.082
Goyanes, 2016, 3D scanning and 3D printing as innovative technologies for fabricating personalized topical drug delivery systems, J. Control. Release, 234, 41, 10.1016/j.jconrel.2016.05.034
Kadry, 2019, Digital light processing (DLP) 3D-printing technology and photoreactive polymers in fabrication of modified-release tablets, Eur. J. Pharm. Sci., 135, 60, 10.1016/j.ejps.2019.05.008
Fina, 2018, 3D printing of drug-loaded gyroid lattices using selective laser sintering, Int. J. Pharm., 547, 44, 10.1016/j.ijpharm.2018.05.044
Sadia, 2018, Channelled tablets: An innovative approach to accelerating drug release from 3D printed tablets, J. Control. Release, 269, 355, 10.1016/j.jconrel.2017.11.022
Isreb, 2019, 3D printed oral theophylline doses with innovative ‘radiator-like’ design: Impact of polyethylene oxide (PEO) molecular weight, Int. J. Pharm., 564, 98, 10.1016/j.ijpharm.2019.04.017
Siyawamwaya, 2019, 3D printed, controlled release, tritherapeutic tablet matrix for advanced anti-HIV-1 drug delivery, Eur. J. Pharm. Biopharm., 138, 99, 10.1016/j.ejpb.2018.04.007
Kavanagh, 2018, Maximising success in multidrug formulation development: A review, J. Control. Release, 283, 1, 10.1016/j.jconrel.2018.05.024
Genina, 2017, Anti-tuberculosis drug combination for controlled oral delivery using 3D printed compartmental dosage forms: From drug product design to in vivo testing, J. Control. Release, 268, 40, 10.1016/j.jconrel.2017.10.003
Pereira, 2019, ‘Temporary Plasticiser’: A novel solution to fabricate 3D printed patient-centred cardiovascular ‘Polypill’ architectures, Eur. J. Pharm. Biopharm., 135, 94, 10.1016/j.ejpb.2018.12.009
Sadia, M., Isreb, A., Abbadi, I., Isreb, M., Aziz, D., Selo, A., Timmins, P., and Alhnan, M.A. (2018). From ‘fixed dose combinations’ to ‘a dynamic dose combiner’: 3D printed bi-layer antihypertensive tablets. Eur. J. Pharm. Sci.
Trenfield, 2018, 3D Printing Pharmaceuticals: Drug Development to Frontline Care, Trends Pharmacol. Sci., 39, 440, 10.1016/j.tips.2018.02.006
Gioumouxouzis, 2018, A 3D printed bilayer oral solid dosage form combining metformin for prolonged and glimepiride for immediate drug delivery, Eur. J. Pharm. Sci., 120, 40, 10.1016/j.ejps.2018.04.020
Goyanes, 2015, 3D Printing of Medicines: Engineering Novel Oral Devices with Unique Design and Drug Release Characteristics, Mol. Pharm., 12, 4077, 10.1021/acs.molpharmaceut.5b00510
Khaled, 2015, 3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles, J. Control. Release, 217, 308, 10.1016/j.jconrel.2015.09.028
Khaled, 2015, 3D printing of tablets containing multiple drugs with defined release profiles, Int. J. Pharm., 494, 643, 10.1016/j.ijpharm.2015.07.067
Awad, 2018, 3D printed medicines: A new branch of digital healthcare, Int. J. Pharm., 548, 586, 10.1016/j.ijpharm.2018.07.024
Beck, 2017, 3D printed tablets loaded with polymeric nanocapsules: An innovative approach to produce customized drug delivery systems, Int. J. Pharm., 528, 268, 10.1016/j.ijpharm.2017.05.074
Goyanes, 2018, PET/CT imaging of 3D printed devices in the gastrointestinal tract of rodents, Int. J. Pharm., 536, 158, 10.1016/j.ijpharm.2017.11.055
Zhang, 2017, Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets, Int. J. Pharm., 519, 186, 10.1016/j.ijpharm.2016.12.049
Kollamaram, 2018, Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs, Int J Pharm, 545, 144, 10.1016/j.ijpharm.2018.04.055
Pietrzak, 2015, A flexible-dose dispenser for immediate and extended release 3D printed tablets, Eur. J. Pharm. Biopharm., 96, 380, 10.1016/j.ejpb.2015.07.027
Alhnan, 2016, Emergence of 3D Printed Dosage Forms: Opportunities and Challenges, Pharm. Res., 33, 1817, 10.1007/s11095-016-1933-1
Goyanes, 2015, 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets, Eur. J. Pharm. Biopharm., 89, 157, 10.1016/j.ejpb.2014.12.003
Gardan, 2016, Additive manufacturing technologies: State of the art and trends, Int. J. Prod. Res., 54, 3118, 10.1080/00207543.2015.1115909
Vitale, A., and Cabral, J. (2016). Frontal Conversion and Uniformity in 3D Printing by Photopolymerisation. Materials, 9.
Wang, 2016, Stereolithographic (SLA) 3D printing of oral modified-release dosage forms, Int. J. Pharm., 503, 207, 10.1016/j.ijpharm.2016.03.016
Martinez, 2017, Fabrication of drug-loaded hydrogels with stereolithographic 3D printing, Int. J. Pharm., 532, 313, 10.1016/j.ijpharm.2017.09.003
Martinez, P.R., Goyanes, A., Basit, A.W., and Gaisford, S. (2018). Influence of Geometry on the Drug Release Profiles of Stereolithographic (SLA) 3D-Printed Tablets. AAPS PharmSciTech.
Fadda, 2009, Physiological bicarbonate buffers: Stabilisation and use as dissolution media for modified release systems, Int. J. Pharm., 382, 56, 10.1016/j.ijpharm.2009.08.003
Liu, 2011, Evolution of a physiological pH6.8 bicarbonate buffer system: Application to the dissolution testing of enteric coated products, Eur. J. Pharm. Biopharm., 78, 151, 10.1016/j.ejpb.2011.01.001
Goyanes, 2015, A dynamic in vitro model to evaluate the intestinal release behaviour of modified-release corticosteroid products, J. Drug Deliv. Sci. Technol., 25, 36, 10.1016/j.jddst.2014.12.002
Goyanes, 2015, Gastrointestinal release behaviour of modified-release drug products: Dynamic dissolution testing of mesalazine formulations, Int. J. Pharm., 484, 103, 10.1016/j.ijpharm.2015.02.051
Merchant, H.A., Frost, J.A., and Basit, A.W. (2014). Apparatus and Method for Testing Medicaments. (15/392,113), U.S. Patent.
Merchant, 2014, Predicting the gastrointestinal behaviour of modified-release products: Utility of a novel dynamic dissolution test apparatus involving the use of bicarbonate buffers, Int. J. Pharm., 475, 585, 10.1016/j.ijpharm.2014.09.003
Trenfield, 2018, 3D printed drug products: Non-destructive dose verification using a rapid point-and-shoot approach, Int. J. Pharm., 549, 283, 10.1016/j.ijpharm.2018.08.002
Yonemochi, 2013, Diffusivity of amorphous drug in solid dispersion, J. Therm. Anal. Calorim., 113, 1505, 10.1007/s10973-013-3039-x
Corcione, 2014, Development and Characterization of Novel Photopolymerizable Formulations for Stereolithography, J. Polym. Eng., 34, 85, 10.1515/polyeng-2013-0224
Rao, 2001, Controlled and complete release of a model poorly water-soluble drug, prednisolone, from hydroxypropyl methylcellulose matrix tablets using (SBE)7m-β-cyclodextrin as a solubilizing agent, J. Pharm. Sci., 90, 807, 10.1002/jps.1034